Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients

M A Montes-Cano1, C de la Horra, F J Dapena

  • 1Department of Internal Medicine, Virgen Del Rocio University Hospital, Seville, Spain. marcoa.montes.exts@juntadeandalucia.es

Insights

Pneumocystis jirovecii (PJP) colonization in cystic fibrosis (CF) patients shows dynamic evolution. Genotype 3 (85T/248C) becomes more prevalent over time in CF patients.

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Molecular Epidemiology

Background:

  • Asymptomatic Pneumocystis jirovecii (PJP) carriage in cystic fibrosis (CF) is known.
  • The molecular epidemiology of PJP in CF patients remains unclear.

Purpose of the Study:

  • To investigate the distribution and evolution of PJP genotypes in CF patients.
  • To clarify the molecular epidemiology of PJP in CF.

Main Methods:

  • Respiratory samples from 33 CF patients were analyzed.
  • Nested PCR and direct sequencing of the mitochondrial large-subunit (mt LSU) rRNA gene were used.
  • Genotyping of PJP isolates was performed.

Main Results:

  • Three distinct PJP genotypes were identified: Genotype 1 (85C/248C) at 36.3%, Genotype 2 (85A/248C) at 15.1%, and Genotype 3 (85T/248C) at 42.4%.
  • Mixed genotypes were found in 6% of samples.
  • A 1-year follow-up revealed continuous colonization/clearance cycles.
  • A trend towards increased colonization with Genotype 3 was observed.

Conclusions:

  • PJP colonization in CF patients is dynamic, involving cycles of clearance and re-colonization.
  • Genotype 3 (85T/248C) shows an accumulating prevalence in CF patients over time.
  • Understanding PJP genotypes in CF is crucial for managing respiratory infections.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...